Showing results (1111-1120 of 1,295) with videos related to
Sort By:
Pageof 130
Journal of Comparative Effectiveness Research|August 22, 2022
Comparative effectiveness of larotrectinib versus entrectinib for the treatment of metastatic NTRK gene fusion cancersKangho Suh, Josh J Carlson, Fang Xia, et al.Journal of Comparative Effectiveness Research|August 4, 2022
Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost-effectiveness analysisPeng-Fei Zhang, Feng Wen, Qiu-Ji Wu, et al.Journal of Comparative Effectiveness Research|May 24, 2021
Implementation of the Connect for Health pediatric weight management program: study protocol and baseline characteristicsMeg Simione, Haley Farrar-Muir, Fernanda Neri Mini, et al.Journal of Comparative Effectiveness Research|May 25, 2021
Access to medicines in the Brazilian Unified Health System's primary health care: assessment of a public policyMariana M Barbosa, Thais A Moreira, Renata Crm Nascimento, et al.Journal of Comparative Effectiveness Research|April 30, 2021
Micronized purified flavonoid fraction in the treatment of hemorrhoidal diseasePhilippe Godeberge, Parvez Sheikh, Varut Lohsiriwat, et al.Journal of Comparative Effectiveness Research|September 16, 2021
Off-label antipsychotic use patterns among Texas Medicaid adults 2013-2016Shuang Chen, Jamie C Barner, Eun ChoJournal of Comparative Effectiveness Research|May 19, 2020
Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost-effectiveness analysisHongfu Cai, Longfeng Zhang, Na Li, et al.Journal of Comparative Effectiveness Research|September 7, 2021
Cost-effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetesMargaret F Zupa, Ronald A Codario, Kenneth J SmithJournal of Comparative Effectiveness Research|June 9, 2022
Unmeasured confounding in nonrandomized studies: quantitative bias analysis in health technology assessmentThomas P Leahy, Seamus Kent, Cormac Sammon, et al.Journal of Comparative Effectiveness Research|June 27, 2022
Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson's disease: a systematic review and meta-analysisMagdalena Żegleń, Katarzyna Śladowska, Paweł Kawalec, et al.Pageof 130